Fibroblast growth factor receptors as targets for anticancer therapy in cholangiocarcinomas and urothelial carcinomas

Cholangiocarcinomas and urothelial carcinomas are lethal tumors worldwide and only a minority of patients are eligible for surgery at diagnosis. Moreover, patients are poorly responsive to current therapeutic strategies, including chemotherapy, radiotherapy, immunotherapy, and multimodality treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Wekking, Demi, Pretta, Andrea, Martella, Serafina, D'Agata, Alessandra Pia, Joeun Choe, Joanna, Denaro, Nerina, Solinas, Cinzia, Scartozzi, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481293/
https://www.ncbi.nlm.nih.gov/pubmed/37681152
http://dx.doi.org/10.1016/j.heliyon.2023.e19541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481293/
https://www.ncbi.nlm.nih.gov/pubmed/37681152
http://dx.doi.org/10.1016/j.heliyon.2023.e19541

Ejemplares similares